usa_2_0217|XENE|Short Name|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
usa_2_0217|XENE|Long Name|Xenon Pharmaceuticals Inc Total Current Assets (Quarterly) (USD)|Xenon Pharmaceuticals Inc Cash and Short Term Investments (Quarterly) (USD)|Xenon Pharmaceuticals Inc Inventories (Quarterly) (USD)|Xenon Pharmaceuticals Inc Net PP&E (Quarterly) (USD)|Xenon Pharmaceuticals Inc Goodwill and Intangibles (Quarterly) (USD)|Xenon Pharmaceuticals Inc Total Liabilities (Quarterly) (USD)|Xenon Pharmaceuticals Inc Total Current Liabilities (Quarterly) (USD)|Xenon Pharmaceuticals Inc Total Long Term Liabilities (Quarterly) (USD)|Xenon Pharmaceuticals Inc Total Deposits (Quarterly) (USD)|Xenon Pharmaceuticals Inc Book Value (Quarterly) (USD)|Xenon Pharmaceuticals Inc Retained Earnings (Quarterly) (USD)|Xenon Pharmaceuticals Inc Treasury Stock (Quarterly) (USD)|Xenon Pharmaceuticals Inc EV to Revenues|Xenon Pharmaceuticals Inc EV to Earnings|Xenon Pharmaceuticals Inc EV to Free Cash Flow|Xenon Pharmaceuticals Inc EV to Assets (Quarterly)|Xenon Pharmaceuticals Inc PS Ratio|Xenon Pharmaceuticals Inc PE Ratio|Xenon Pharmaceuticals Inc Price to Book Value|Xenon Pharmaceuticals Inc PEG Ratio|Xenon Pharmaceuticals Inc Debt to Equity Ratio|Xenon Pharmaceuticals Inc Dividend Yield|Xenon Pharmaceuticals Inc Shareholder Yield (TTM)|Xenon Pharmaceuticals Inc Percent of Shares Outstanding Short|Xenon Pharmaceuticals Inc Total Receivables (Quarterly) (USD)|Xenon Pharmaceuticals Inc Total Payables (Quarterly) (USD)|Xenon Pharmaceuticals Inc Total Capital Stock (Quarterly) (USD)|Xenon Pharmaceuticals Inc Return on Invested Capital|Xenon Pharmaceuticals Inc Quality Ratio Score|Xenon Pharmaceuticals Inc Momentum Score|Xenon Pharmaceuticals Inc Beta (1Y)|Xenon Pharmaceuticals Inc Sustainable Growth Rate (TTM)|Xenon Pharmaceuticals Inc Institutional Investor Ownership Percentage|Xenon Pharmaceuticals Inc Average Diluted Shares Outstanding (Quarterly)|Xenon Pharmaceuticals Inc Total Employees (Annual)|Xenon Pharmaceuticals Inc EPS Diluted (Quarterly) (USD)|Xenon Pharmaceuticals Inc Dividend Per Share (Quarterly) (USD)|Xenon Pharmaceuticals Inc Revenue (Quarterly) (USD)|Xenon Pharmaceuticals Inc Gross Profit (Quarterly) (USD)|Xenon Pharmaceuticals Inc SG&A Expense (Quarterly) (USD)|Xenon Pharmaceuticals Inc Pre-Tax Income (Quarterly) (USD)|Xenon Pharmaceuticals Inc Net Income (Quarterly) (USD)|Xenon Pharmaceuticals Inc Net Interest Income (Quarterly) (USD)|Xenon Pharmaceuticals Inc Price (USD)|Xenon Pharmaceuticals Inc Total Return Price (USD)|Xenon Pharmaceuticals Inc Enterprise Value (USD)|Xenon Pharmaceuticals Inc 30-Day Average Daily Volume|Xenon Pharmaceuticals Inc 1 Year Price Returns (Daily)||
usa_2_0217|XENE|Unit|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
usa_2_0217|XENE|201309||||||||||||||||||||||||||||||||||2.0801||0.63||10.788||1.692|6.378|6.378|0.102|||||||
usa_2_0217|XENE|201312|49.869|49.276||1.879||30.371|18.203|12.168||-78.372|-116.752||||||||||0||||0.44|0.657|108.635|||||||9.8281||0.2558||5.583||0.821|2.514|2.514|0.137|||||||
usa_2_0217|XENE|201403||||||||||||||||||||||||||||||||||9.8281||0||5.001||1.436|1.373|1.373|0.141|||||||
usa_2_0217|XENE|201406|45.208|44.71||2.024||23.606|17.231|6.375||27.106|-114.149||||||||||0||||0.364|0.895|108.782|||||||9.8281||0||5.298||1.354|1.23|1.23|0.137|||||||
usa_2_0217|XENE|201409|48.269|47.936||1.999||19.165|16.343|2.822||-67.509|-104.958||||||||||0||||0.162|0.884|108.686|49.7952||||||13.5797|74|0.2647||13.193||1.316|9.191|9.191|0.138||||||10.5|10.5
usa_2_0217|XENE|201412|84.942|84.041||2.476||14.639|14.286|0.353||72.779|-103.734||6.9101|15.0591|-155.2175|2.2426|8.2525|21.2549|3.8484||0|0|-15.2256|0.0239|0.215|0.633|147.157|32.7538||||||14.1813|74|0.6645||4.878||1.39|1.224|1.224|0.152|19.75|19.75|196.0397|49711.1||20.9|20.9
usa_2_0217|XENE|201503|77.05|75.381||2.353||10.434|10.254|0.18||-78.539|-107.999||5.4744|125.346|-119.8151|3.9291|7.0324|58.3162|3.2887||0|0|-17.8296|0.12|1.205|0.687|147.508|4.8844||||||14.2126||-0.64||4.01||6.72|-9.156|-9.156|0.152|16.55|16.55|155.3085|31057.6333||16.51|16.51
usa_2_0217|XENE|201506|74.353|73.7||2.174||12.18|12.016|0.164||-83.477|-111.801||9.3124|98.3209|-45.0429|3.1182|6.0781|52.6006|||0|0|-26.0503|0.059|0.188|0.899|147.824|4.5249||||||15.13||-0.07||4.046||0.178|1.168|1.168|0.163|12.57|12.57|254.9632|52694||9.88|9.88
usa_2_0217|XENE|201509|66.114|65.469||2.13||5.485|5.336|0.149||-83.9|-115.754||11.6888|-19.0137|-33.5675|2.8791|6.9308|37.1352|||0|0|-35.9829|0.2251|0.274|0.843|148.359|-17.332||||||14.2986||-0.27||4.294||1.321|-3.827|-3.827|0.13|8.58|8.58|201.3739|35121.1667||8.28|8.28
usa_2_0217|XENE|201512|60.866|58.651||1.989||2.915|2.782|0.133||61.034|-119.693||11.6456|-3.619|-12.0365|0.8914|6.872||||0|0|0|0.1152|0.315|1.143|148.634|-23.7524||3|1.2966|||14.3743|83|-0.27||3.227||1.567|-3.937|-3.937|0.097|8.46|8.46|200.6311|14741.2|-50.3667|7.96|7.96
usa_2_0217|XENE|201603|58.268|56.064||1.79||2.989|2.872|0.117||-90.565|-122.956||2.3552|-19.6096|-1.9436|3.1615|6.1639||1.5621||0|0|0.1262|0.0893|0.386|1.056|148.728|-15.5518||2|0.9158|||14.394||-0.23||0.601||1.895|-3.263|-3.263|0.099|6.59|6.59|36.6876|41743|-60.6567|6.96|6.96
usa_2_0217|XENE|201606|53.392|50.738||1.663||3.03|2.929|0.101||-96.21|-128.972||14.6705|-10.7481|-9.826|3.2894|7.1263||||0|0|0.2504|0.2771|0.658|0.702|148.867|-28.3426||2|0.8409|||14.4346||-0.42||0.413||1.676|-6.016|-6.016|0.123|5.88|5.88|178.5112|16990.5|-51.7637|6.33|6.33
usa_2_0217|XENE|201609|71.35|69.491||1.542||4.062|3.976|0.086||-103.577|-136.704||25.5771|-11.8647|-10.237|3.3845|14.0301|||-0.016|0|0|-16.4435|0.1797|0.595|0.538|172.886|-34.2416||3|1.0608|||15.269||-0.51||0.413||1.779|-7.714|-7.714|0.114|8.15|8.15|218.3009|55246.7|-3.5503|7.62|7.62
usa_2_0217|XENE|201612|65.675|64.146||1.404||3.586|3.586|0||63.901|-142.681||51.8207|-3.2143|-12.222|1.0953|24.1853|||-0.0163|0|0|-17.2614|0.3837|0.2|1.592|173.246|-37.6921||3|1.7747|||17.9028|94|-0.32||0.376||1.442|-6.004|-6.004|0.168|8.25|8.25|241.1734|28566.7333|1.601|7.85|7.85
usa_2_0217|XENE|201703|59.141|58.027||1.376||3.591|3.591|0||-116.634|-150.201||5.2089|-6.8911|-0.3377|3.0893|35.247||1.1087|-0.1597|0|0|-33.1061|0.6826|0.189|1.261|173.829|-45.2336||4|4.4861|||17.9745||-0.43||0.016||2.1|-7.517|-7.517|0.149|4.35|4.35|6.7012|251640.8667|-34.7826|4.15|4.15
usa_2_0217|XENE|201706|52.633|51.696||1.308||3.774|3.774|0||-123.389|-157.581||140.8799|-6.2499|-8.0543|3.298|41.7284|||-0.0179|0|0|-42.0355|0.9715|0.198|1.38|173.841|-48.7455||2|4.6746|||18.0157||-0.41||0.015||1.799|-7.38|-7.38|0.109|3|3|172.4916|87754.0667|-50|3.25|3.25
usa_2_0217|XENE|201709|44.987|43.772||1.154||3.058|3.058|0||-130.54|-165.323||214.8051|-6.3947|-7.6573|3.951|63.2579|||-0.0445|0|0|0|0.8464|0.129|0.872|173.841|-50.3998||1|3.5066|||18.01||-0.43||0.264|0.264|1.744|-7.742|-7.742|0.124|3|3|174.3404|37734.3333|-63.1902|2.925|2.925
usa_2_0217|XENE|201712|44.821|43.667||1.07||10.187|4.083|6.104||35.934|-173.388||269.6192|-0.4554|-6.741|0.3032|76.3501|||-0.1602|0.1893|0|-2.6763|0.7789|0.438|1.297|173.841|-59.5993||1|3.6898|||18.0068|81|-0.45||0.016|0.016|1.67|-8.065|-8.065|0.095|2.825|2.825|180.9145|106059.9333|-64.8485|2.925|2.925
usa_2_0217|XENE|201803|36.661|35.078||1.101||9.264|3.788|5.476||6.673|-177.143|||-2.3407|-2.0446|1.67|283.629|||-0.1667|0.2413|0|-1.9804|1.06|0.432|0.536|169.712|-58.8099|||-2.6275|||17.8044||-0.21||||2.238|-3.743|-3.755|-0.051|4.75|4.75|63.0624|75496.4333|4.3956|4.85|4.85
usa_2_0217|XENE|201806|64.35|63.27||1.086||14.815|3.094|11.721||28.796|-184.944|||-4.845|-3.4002|2.026|||19.5391||0.2315|0|-19.2863|3.3365|0.171|0.913|198.837|-58.4163||9|-3.5797|||14.3065||-0.45||||2.178|-7.809|-7.801|-0.075|7.85|7.85|104.8748|197975.5|106.5789|9.5|9.5
usa_2_0217|XENE|201809|129.493|127.128||0.962||19.299|4.413|14.886||99.224|-199.327|||-6.8275|-10.2089|1.7796|||11.4883||0.1339|0|-31.8278|1.112|0.18|1.021|273.587|-54.8811||10|-2.5083|-424.1275||20.3063||-0.63|||-6|1.938|-14.391|-14.383|-0.353|13.25|13.25|302.3462|278787.4667|365.5172|12.62|12.62
usa_2_0217|XENE|201812|121.332|119.306||0.991||19.133|4.119|15.014||95.563|-207.885|||-1.9111|-1.2691|0.5385|||1.5059|-0.3485|0.1454|0|-65.1454|0.8122|0.151|0.75|273.655|-44.824||10|2.2609|-64.7977||25.2856|92|-0.29|||0|2.052|-8.578|-8.558|0.301|5.72|5.72|44.0645|193015.4333|123.3628|6.68|6.68
usa_2_0217|XENE|201903|112.047|110.429||2.431||22.237|6.376|15.861||84.581|-219.401|||-4.1415|-4.1446|1.5215|||2.7378||0.164|0|-39.9158|1.5702|0.132|1.209|273.772|-46.8089||10|3.2321|-66.833||25.7538||-0.42||||2.621|-11.304|-11.341|0.324|9.42|9.42|146.0172|116868.8333|103.9583|10.45|10.45
usa_2_0217|XENE|201906|103.325|101.801||2.451||23.105|9.33|13.775||75.055|-229.408|||-3.9591|-4.5008|1.6559|||2.9131|-0.2791|0.1844|0|-29.7359|1.9112|0.171|1.62|273.794|-43.234||10|2.0716|-57.7855||25.7756||-0.37||||2.307|-10.036|-10.007|0.341|9.66|9.66|161.4092|90907.1667|19.5|10.05|10.05
usa_2_0217|XENE|201909|96.478|94.603||2.248||24.34|11.697|12.643||66.832|-238.279|||-4.1676|-4.1707|1.634|||3.1491|-0.4646|0.2066|0|-0.3193|1.0742|0.209|1.516|274.157|-35.9163||3|1.7967|-46.0256||25.7935||-0.33||3.5|3.5|2.7|-8.866|-8.871|0.165|9.4|9.4|163.4859|43857.6|-32.0741|8.99|8.99
usa_2_0217|XENE|201912|144.866|141.358||2.593||55.72|43.379|12.341||84.245|-249.655|||-6.03|-9.3682|1.6982|||4.379||0.1689|0|-7.4617|1.5275|0.813|2.668|301.976|-39.8955||9|1.1318|-51.1906||26.4364|104|-0.41||3.329|3.329|3.175|-11.412|-11.376|0.089|13.75|13.75|303.7548|206840.4|107.7655|13.72|13.72
usa_2_0217|XENE|202003|233.87|229.671||2.987||49.065|48.524|0.541||180.246|-257.139|||-5.0385|-48.0522|0.8021|||2.1992||0.0834|0|-32.7909|1.6097|1.617|3.232|405.039|-31.1039||10|0.9321|-38.4329||33.1897||-0.22||7.078||3.32|-7.485|-7.484|0.786|11.45|11.45|282.1626|278936.9667|11.6142|10.99|10.99
usa_2_0217|XENE|202006|207.01|202.754||3.376||21.378|21.055|0.323||181.566|-257.314|||-8.7369|-23.6333|1.1573|13.8306||2.4169||0|0|-28.9002|2.622|1.786|1.661|405.384|-20.2661||9|1.3615|-23.7319||34.9793||-0.0049||13.384||3.31|-0.214|-0.175|0.758|13.03|13.03|249.4495|274630.6|27.1805|12.81|12.81
usa_2_0217|XENE|202009|||||||||||||6.7668||-14.54||11.9446||2.0874|||0||3.9014||||||8|1.2183|||||||||||||10.85|10.85|184.6727|93668.3667|23.4892|11.19|11.19